Therefore, despite existing data on the correlation between MCP-1 levels and the diagnosis and prognosis of tubulointerstitial damage and repair, little is known about its efficacy in the diagnosis and prognosis of AKI and/or in humans [73]. The gene discussed is CCL2; the disease is acute kidney injury.